A peptidomimetic that specifically inhibits human leukocyte antigen DRB1*0401-restricted T cell proliferation.

Autor: L, Woulfe S, P, Bono C, L, Zacheis M, K, Welply J, A, Kirschmann D, A, Baudino T, Y, Wang, A, Stone D, J, Hanson G, L, Vuletich J, J, Bedell L, D, Schwartz B, C, Howard S

Publikováno v: The Journal of Pharmacology and Experimental Therapeutics; May 1997, Vol. 281 Issue: 2 p663-9, 7p